Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study.

OBJECTIVE To determine whether flavonoid intake explains differences in mortality rates from chronic diseases between populations. DESIGN Cross-cultural correlation study. SETTING/PARTICIPANTS Sixteen cohorts of the Seven Countries Study in whom flavonoid intake at baseline around 1960 was estimated by flavonoid analysis of equivalent food composites that represented the average diet in the cohorts. MAIN OUTCOME MEASURES Mortality from coronary heart disease, cancer (various sites), and all causes in the 16 cohorts after 25 years of follow-up. RESULTS Average intake of antioxidant flavonoids was inversely associated with mortality from coronary heart disease and explained about 25% of the variance in coronary heart disease rates in the 16 cohorts. In multivariate analysis, intake of saturated fat (73%; P = 0.0001), flavonoid intake (8%, P = .01), and percentage of smokers per cohort (9%; P = .03) explained together, independent of intake of alcohol and antioxidant vitamins, 90% of the variance in coronary heart disease rates. Flavonoid intake was not independently associated with mortality from other causes. CONCLUSIONS Average flavonoid intake may partly contribute to differences in coronary heart disease mortality across populations, but it does not seem to be an important determinant of cancer mortality.

[1]  H. Mukhtar,et al.  Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. , 1988, Cancer research.

[2]  Peter C. H. Hollman,et al.  Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands , 1992 .

[3]  G. Wong,et al.  Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. , 1991, Carcinogenesis.

[4]  L. Larocca,et al.  Growth‐inhibitory effect of quercetin and presence of type‐II estrogen‐binding sites in human colon‐cancer cell lines and primary colorectal tumors , 1992, International journal of cancer.

[5]  A. Keys,et al.  Food consumption patterns in the 1960s in seven countries. , 1989, The American journal of clinical nutrition.

[6]  J. Kuhnau.  The flavonoids. A class of semi-essential food components: their role in human nutrition. , 1976 .

[7]  D. Forman,et al.  An international association between Helicobacter pylori infection and gastric cancer , 1993 .

[8]  D Kromhout,et al.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. , 1993, Nutrition and cancer.

[9]  P. Hollman,et al.  CONTENT OF POTENTIALLY ANTICARCINOGENIC FLAVONOIDS OF TEA INFUSIONS, WINES, AND FRUIT JUICES , 1993 .

[10]  A Keys,et al.  The diet and 15-year death rate in the seven countries study. , 1986, American journal of epidemiology.

[11]  R. Gryglewski,et al.  Flavonoids are scavengers of superoxide anions. , 1988, Biochemical pharmacology.

[12]  W. Willett.  The search for the causes of breast and colon cancer , 1989, Nature.

[13]  M. Huang,et al.  Inhibitory effect of green tea on tumorigenesis by chemicals and ultraviolet light. , 1992, Preventive medicine.

[14]  E. Feskens,et al.  Dietary flavonoids and cancer risk in the Zutphen Elderly Study. , 1994, Nutrition and cancer.

[15]  Peter C. H. Hollman,et al.  Optimization of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetables and fruits , 1992 .

[16]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[17]  A. Nègre-Salvayre,et al.  Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. , 1992, Free radical biology & medicine.

[18]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[19]  U. Takahama.  Inhibition of lipoxygenase-dependent lipid peroxidation by quercetin: Mechanism of antioxidative function , 1985 .

[20]  E. Parks,et al.  Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine , 1993, The Lancet.

[21]  M. A. Tanner,et al.  Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. , 1988, Cancer research.

[22]  H. Blackburn,et al.  Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. , 2009, Acta medica Scandinavica. Supplementum.

[23]  J. Cillard,et al.  Hydroxyl radical scavenging activity of flavonoids , 1987 .

[24]  R. Severson,et al.  A prospective study of stomach cancer and its relation to diet, cigarettes, and alcohol consumption. , 1990, Cancer research.

[25]  E. Wynder,et al.  Ecologic Study of Lung Cancer Risk Factors in the U.S. and Japan, with Special Reference to Smoking and Diet , 1992, Japanese journal of cancer research : Gann.

[26]  S. Rankin,et al.  Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. , 1990, Biochemical pharmacology.